Qualigen Therapeutics (QLGN) announced they will be the first investors participating in the 2025 bridge round of funding for NanoSynex.

CARLSBAD, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the "Company”)announced today ...

Becca Rubenfeld and the AnchorWatch team recently unveiled a first-of-its-kind bitcoin custody plus insurance solution, which ...

Maryam Hassani’s commitment to leveling the playing field in technology was the primary incentive for her to build Zealous, ...

The storm created by DeepSeek in the field of innovative technology has raised a lot of questions, including how it is ...

Small and medium-sized enterprises (SMEs) drive much of Trinidad and Tobago’s (T&T’s) economy, however, financing remains a ...

Ampol's fourth-quarter 2024 Lytton refiner margin was 56% below the previous corresponding period at USD 4.60 per barrel. The refined fuel retailer is guiding for underlying 2024 EBIT and EBITDA of ...

DeepSeek’s achievement is an example of optimal use of restricted resources and a lesson for India in plain sight, especially ...

Being a family wealth manager helped Sophia Jarvis to spot a gap in the market with a lack of investment apps aimed at ...

We couldn’t be happier with the Citibank campus,” says Harrison Loew, director of acquisitions with The Wideman Co. of ...

The Apple MacBook Pro 16 (2024, M4 Pro) is the best laptop that I've ever used. And if you were using M1 before, it might ...